Institutional Ownership Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC). We have compiled data on the 234 institutions that hold shares in the stock, with a total of 82.8 Million shares, which have been reported (via 13F filing form) to have a value of $213 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Gabelli & CO Investment Advisers, Inc.
Rye, NY |
Nov 13, 2024 Q3 2024 |
839,800
shares
|
$2.16 Million
0.4% of portfolio
|
Q3 2024
New holding
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
Nov 13, 2024 Q3 2024 |
820,000
shares
|
$2.11 Million
2.69% of portfolio
|
Q3 2024
Reduced 70.71%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
797,953
shares
|
$2.05 Million
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
790,837
shares
|
$2.03 Million
0.0% of portfolio
|
Q3 2024
Added 5.5%
|
|
|
Rice Hall James & Associates, LLC
|
Oct 28, 2024 Q3 2024 |
730,190
shares
|
$1.88 Million
0.11% of portfolio
|
Q3 2024
Added 2.54%
|
|
|
Oddo Bhf Asset Management Sas
Paris, I0 |
Dec 03, 2024 Q3 2024 |
725,000
shares
|
$1.86 Million
0.19% of portfolio
|
Q3 2024
New holding
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
699,621
shares
|
$1.8 Million
0.0% of portfolio
|
Q3 2024
Added 14.54%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
632,553
shares
|
$1.63 Million
0.0% of portfolio
|
Q3 2024
Added 1145.85%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
568,654
shares
|
$1.46 Million
0.0% of portfolio
|
Q3 2024
Added 246.92%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
567,300
shares
|
$1.46 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
Nov 14, 2024 Q3 2024 |
522,716
shares
|
$1.34 Million
0.01% of portfolio
|
Q3 2024
Added 1231.15%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
459,300
shares
|
$1.18 Million
0.0% of portfolio
|
Q3 2024
Reduced 19.7%
|
|
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
Nov 14, 2024 Q3 2024 |
457,085
shares
|
$1.17 Million
0.34% of portfolio
|
Q4 2021
Reduced 3.28%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
455,313
shares
|
$1.17 Million
0.0% of portfolio
|
Q3 2024
Reduced 56.89%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
446,027
shares
|
$1.15 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Rothschild & CO Asset Management Us Inc.
New York, NY |
Feb 14, 2023 Q4 2022 |
369,648
shares
|
$949,995
0.1% of portfolio
|
Q4 2022
Added 71.98%
|
|
|
Exome Asset Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
347,600
shares
|
$893,332
1.24% of portfolio
|
Q3 2024
New holding
|
|
|
Man Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
300,000
shares
|
$771,000
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
288,726
shares
|
$742,025
1.12% of portfolio
|
Q2 2023
Added 57.77%
|
|
|
Brandywine Global Investment Management, LLC
Philadelphia, PA |
Nov 12, 2024 Q3 2024 |
283,800
shares
|
$729,366
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2024 Q3 2024 |
275,000
shares
|
$706,750
0.13% of portfolio
|
Q3 2024
New holding
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
265,210
shares
|
$681,589
0.0% of portfolio
|
Q3 2024
Added 11.53%
|
|
|
Alpha Centric Advisors LLC
San Juan, PR |
Oct 30, 2024 Q3 2024 |
245,000
shares
|
$629,650
0.53% of portfolio
|
Q1 2024
Added 11.36%
|
|
|
Alberta Investment Management Corp
Edmonton, A0 |
Nov 05, 2024 Q3 2024 |
240,000
shares
|
$616,800
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Wolverine Asset Management LLC
|
Nov 04, 2024 Q3 2024 |
231,400
shares
|
$594,698
0.01% of portfolio
|
Q3 2024
Added 9141.21%
|